CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $28,799,000 | +12207.3% | 852,040 | +8420.4% | 0.02% | – |
| Q1 2021 | $234,000 | -97.5% | 10,000 | -96.9% | 0.00% | -100.0% |
| Q4 2020 | $9,293,000 | -0.1% | 322,684 | -29.7% | 0.01% | -36.4% |
| Q3 2020 | $9,305,000 | +38.8% | 459,286 | +105.9% | 0.01% | +22.2% |
| Q2 2020 | $6,704,000 | -53.4% | 223,101 | -51.2% | 0.01% | -71.9% |
| Q1 2020 | $14,381,000 | -47.3% | 457,568 | -20.9% | 0.03% | -8.6% |
| Q4 2019 | $27,267,000 | +16941.9% | 578,799 | +2332.2% | 0.04% | – |
| Q3 2018 | $160,000 | – | 23,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |